Personalized care for Rh-negative pregnant women: digital labeling of immunological medicines

Relevance. The organization of personalized care with immunological medicines for the prevention of rhesus conflict in Rh-negative pregnant women in outpatient departments of a medical organization using digital labelling is currently relevant.
Methodology. The research used methods of content analysis, grouping, structural and comparative analysis. The analysis of regulatory documentation in the field of treatment of labelled immunological drugs; Clinical recommendations: obstetrics and gynecology; local documents and business processes of the pharmacy of a medical organization, women's consultations, gynecological offices of polyclinics during the prevention of Rh conflict in pregnant women.
Results. Insufficient implementation of digital labelling of immunobiological drugs in outpatient departments of a medical organization has been revealed. The directions of personalized medical care for pregnant women are substantiated: organizational, technical, and educational. Methodological recommendations have been developed for specialists of a medical organization.
Conclusion. The digital labelling of immunobiological drugs will ensure the personalization of drug care for Rh-negative pregnant women in antenatal clinics and polyclinics.

1. Tikhonov A.V., Umarov S.Z., Korunzhaya A.A. Analysis of the pharmaceutical industry digital transformation: positive and negative consequences. Pharmacoeconomics: theory and practice. 2023;11(№2): 64-65. (In Russ.].

2. The State Register of Medicines. (Electronic resource). URL: https://grls.rosminzdrav.ru / (accessed: 22.12.2023).

3. Rubricator of clinical recommendations of the Ministry of Health of the Russian Federation (Electronic resource). (accessed: 21.12.2023).

4. Order of the Ministry of Health of the Russian Federation dated 11/30/2015 No. 866 "On Approval of the Concept of Creating a Federal State Information System for monitoring the movement of medicines from the manufacturer to the end user using labeling". (Electronic resource). (accessed: 22.12.2023).

5. Sokolova A.V., Isaeva I.Y. Information interaction of structural divisions of a medical organization. Global vectors of development of pharmaceutical education, science and practice in an unpredictable external environment and digitalization: materials of the XI All-Russian Interuniversity Scientific and Practical Conference. Kolomna, 2023-21-23-09; (1):107-110. (In Russ.).

6. Lavrentieva L.I., Isaeva I.Y. Organizational problems of the hospital pharmacy in modern conditions. Modern organization of drug provision. 2021;(1):93-95. (In Russ.).

7. Karakozova V.V., Knysh V.V., Karakozov S.V. Organizational and methodological solution to the problem of registration of the retirement of labeled medicines from circulation in a pharmacy of a medical organization. Modern problems of healthcare and medical statistics. 2021;(4): 23-37 (In Russ.).

8. Sokolova A.V., Isaeva I.Y. Features of drug provision for women during pregnancy. Pharmacoeconomics: theory and practice. 2023;11(2): 54. (In Russ.).

9. Federal Law No. 61-FZ of 12.04.2010 «On Circulation of Medicines». (Electronic resource).

10. Letter of Roszdravnadzor dated 11/28/2019 No. 01I-2906/19 «On putting into civil circulation». (Electronic resource). (accessed: 22.12.2023)

11. Order of the Ministry of Health dated 28.112005 No. 701 «On the generic certificate». (Electronic resource). (accessed: 22.12.2023)